Почетна › Акутна миелоидна леукемија › Мичиген › Ann Arbor
Клинички испитувања за Акутна миелоидна леукемија во Ann Arbor, MI
17 студии за Акутна миелоидна леукемија бараат учесници на локации во и околу Ann Arbor (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Се регрутираФаза 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · на 7 милји
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · на 15 милји
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · на 18 милји
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Се регрутираФаза 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · на 7 милји
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · на 15 милји
- и уште 1
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Се регрутираФаза 1
- C S Mott Children's Hospital, Ann Arbor
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · на 7 милји
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · на 7 милји
- и уште 4
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Се регрутираФаза 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · на 7 милји
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · на 15 милји
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · на 18 милји
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Се регрутираФаза 3
- Trinity Health Michigan Heart - Ann Arbor Campus, Ypsilanti · на 7 милји
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Се регрутираФаза 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · на 7 милји
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · на 15 милји
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · на 18 милји
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Се регрутираФаза 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · на 7 милји
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · на 15 милји
- и уште 1
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Се регрутираФаза 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · на 7 милји
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · на 15 милји
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · на 18 милји
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Се регрутираФаза 3
- C S Mott Children's Hospital, Ann Arbor
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Се регрутираФаза 3
- C S Mott Children's Hospital, Ann Arbor
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Се регрутираФаза 1/2
- C S Mott Children's Hospital, Ann Arbor
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Се регрутираФаза 3
- C.S. Mott Children's Hospital, Ann Arbor
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Се регрутираФаза 3
- University of Michigan, Ann Arbor
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Се регрутираНабљудувачка студија
- University of Michigan, Ann Arbor
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Се регрутираФаза 1
- University of Michigan, Ann Arbor
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Се регрутираФаза 1
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Испитувања за Акутна миелоидна леукемија во други градови
- Houston, TX85 студии
- New York City, NY51 студија
- Boston, MA44 студии
- Seattle, WA41 студија
- Baldwin Park, CA40 студии
- Columbus, OH35 студии
- Philadelphia, PA34 студии
- Durham, NC33 студии
- Atlanta, GA31 студија
- Tampa, FL29 студии
- Chicago, IL26 студии
- Portland, OR25 студии
Други студии во Ann Arbor
- Рак на дојка27 студии
- Рак на простата27 студии
- Рак на бели дробови со не-мали клетки26 студии
- Рак (сите типови)25 студии
- Рак на бели дробови23 студии
- Колоректален карцином23 студии
- Срцева слабост22 студии
- Кардиоваскуларни болести16 студии
- Карцином на панкреасот14 студии
- Меланом12 студии
- Шлог12 студии
- Сквамозноклеточен карцином на глава и врат12 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.